fda warning letters bpc-157 compounding pharmacies issued 25 to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Warns 25 Firms Over
FDA Warns 25 Firms Over Compounded GLP 1 Claims FDA's confusing warning letters FDA advisory committee votes to add popular peptide BPC 157 to drug compounding list ABC News Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law
Pay in 4 interest-free payments of $5.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



